고정식 및 이동식 C암 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Fixed And Mobile C-arms Market Growth & Trends:

The global fixed and mobile C-arms market size is expected to reach USD 4.23 billion in 2030 and is expected to expand at a CAGR of 4.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Constant technological advancements in C-arm technology and the growing number of surgical procedures are the primary factors driving the growth of the market. In addition, an increase in the number of the geriatric population prone to various chronic disorders is expected to further boost the market growth.

C-arm technology has progressed rapidly with the introduction of mobile and mini C-arms. Its mobility and image quality allow surgeons to track surgery progress at any moment and identify areas for improvement instantly. As a result, treatment outcomes are better, eventually leading to faster patient recovery, further reducing follow-up operations. Furthermore, the introduction of Flat Panel Detectors (FPD) in C-arms has helped in reducing the radiation dose.

The rising prevalence and awareness of chronic diseases like neurological conditions, orthopedics, and cardiovascular diseases, which may require surgical interventions are expected to fuel the growth of the market during the forecast period. Furthermore, a rise in the geriatric population that is more prone to chronic disorders, a growing preference for minimally invasive surgical procedures, and increasing patient awareness are also expected to boost the growth.

Leading manufacturers in the market are implementing various strategies such as acquisition, funding, and product development to expand their product portfolio and manufacturing capacity. For instance, in April 2021, Carestream Health, in collaboration with Ziehm Imaging, announced the addition of a mobile C-arm to its increasing innovative product line. The Ziehm Vision RFD C-arm is expected to expand Carestream's mobile and fluoroscopic product offerings to benefit even more healthcare providers.

Fixed And Mobile C-arms Market Report Highlights:

• The fixed C-arms segment dominated the market in 2024. Fixed C-arms are particularly adopted in large hospitals and surgical centers for complex procedures that require continuous and precise imaging.
• Mobile C-arms is expected to grow at the fastest CAGR of 4.5% over the forecast period
• The orthopedics and trauma segment dominated the fixed and mobile C-arms market and accounted for the largest revenue share of 26.9% in 2024
• The cardiovascular segment is expected to grow at the fastest CAGR of over 4.7% during the forecast period
• Hospitals dominated the market by capturing a share of 46.3% in 2024. This is due to the high demand for advanced imaging technologies in hospitals, where C-arms are extensively used for various orthopedic, cardiovascular, and trauma surgeries

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Fixed and Mobile C-arms Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Growing number of surgical procedures
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Increasing geriatric population
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of C-arm system
    • 3.2.2.2. Complex regulatory environment
• 3.3. Fixed and Mobile C-arms Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Fixed and Mobile C-arms Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Fixed and Mobile C-arms Product Market Movement Analysis
• 4.3. Global Fixed and Mobile C-arms Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Fixed C-arms
  • 4.4.1. Fixed C-arms market estimates and forecasts 2018 - 2030 (USD Million)
• 4.5. Mobile C-arms
  • 4.5.1. Mobile C-arms market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.1.1. Full size C-arms
      • 4.5.1.1.1. Full size C-arms market estimates and forecasts 2018 - 2030 (USD Million)
    • 4.5.1.2. Mini C-arms
      • 4.5.1.2.1. Mini C-arms market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Fixed and Mobile C-arms Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Fixed and Mobile C-arms Application Market Movement Analysis
• 5.3. Global Fixed and Mobile C-arms Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Orthopedics and Trauma
  • 5.4.1. Orthopedics and trauma market estimates and forecasts 2018 - 2030 (USD Million)
• 5.5. Neurosurgery
  • 5.5.1. Neurosurgery market estimates and forecasts 2018 - 2030 (USD Million)
• 5.6. Cardiovascular
  • 5.6.1. Cardiovascular market estimates and forecasts 2018 - 2030 (USD Million)
• 5.7. Pain Management
  • 5.7.1. Pain management market estimates and forecasts 2018 - 2030 (USD Million)
• 5.8. Gastroenterology
  • 5.8.1. Gastroenterology market estimates and forecasts 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Fixed and Mobile C-arms Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Fixed and Mobile C-arms End Use Market Movement Analysis
• 6.3. Global Fixed and Mobile C-arms Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market estimates and forecasts 2018 - 2030 (USD Million)
• 6.5. Ambulatory Surgical Centers
  • 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 - 2030 (USD Million)
• 6.6. Research Institutions
  • 6.6.1. Research institutions market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Fixed and Mobile C-arms Market: Regional Estimates & Trend Analysis By Product, Application, End Use

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.5. North America
  • 7.5.1. U.S.
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Competitive scenario
    • 7.5.1.3. Regulatory framework
    • 7.5.1.4. Reimbursement structure
    • 7.5.1.5. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.2. Canada
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement structure
    • 7.5.2.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.3. Mexico
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement structure
    • 7.5.3.5. Canada market estimates and forecasts 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. UK
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Competitive scenario
    • 7.6.1.3. Regulatory framework
    • 7.6.1.4. Reimbursement structure
    • 7.6.1.5. UK market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.2. Germany
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement structure
    • 7.6.2.5. Germany market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.3. France
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement structure
    • 7.6.3.5. France market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.4. Italy
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement structure
    • 7.6.4.5. Italy market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.5. Spain
    • 7.6.5.1. Key country dynamics
    • 7.6.5.2. Competitive scenario
    • 7.6.5.3. Regulatory framework
    • 7.6.5.4. Reimbursement structure
    • 7.6.5.5. Spain market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.6. Norway
    • 7.6.6.1. Key country dynamics
    • 7.6.6.2. Competitive scenario
    • 7.6.6.3. Regulatory framework
    • 7.6.6.4. Reimbursement structure
    • 7.6.6.5. Norway market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.7. Sweden
    • 7.6.7.1. Key country dynamics
    • 7.6.7.2. Competitive scenario
    • 7.6.7.3. Regulatory framework
    • 7.6.7.4. Reimbursement structure
    • 7.6.7.5. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.8. Denmark
    • 7.6.8.1. Key country dynamics
    • 7.6.8.2. Competitive scenario
    • 7.6.8.3. Regulatory framework
    • 7.6.8.4. Reimbursement structure
    • 7.6.8.5. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement structure
    • 7.7.1.5. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement structure
    • 7.7.2.5. China market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement structure
    • 7.7.3.5. India market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement structure
    • 7.7.4.5. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement structure
    • 7.7.5.5. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement structure
    • 7.7.6.5. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement structure
    • 7.8.1.5. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement structure
    • 7.8.2.5. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement structure
    • 7.9.1.5. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement structure
    • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement structure
    • 7.9.3.5. UAE market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key country dynamics
    • 7.9.4.2. Competitive scenario
    • 7.9.4.3. Regulatory framework
    • 7.9.4.4. Reimbursement structure
    • 7.9.4.5. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Key company market share analysis, 2024
• 8.4. Company Position Analysis
• 8.5. Company Categorization (Emerging Players, Innovators and Leaders
• 8.6. Company Profiles
  • 8.6.1. GE HealthCare
    • 8.6.1.1. Company overview
    • 8.6.1.2. Financial performance
    • 8.6.1.3. Product benchmarking
    • 8.6.1.4. Strategic initiatives
  • 8.6.2. Koninklijke Philips N.V.
    • 8.6.2.1. Company overview
    • 8.6.2.2. Financial performance
    • 8.6.2.3. Product benchmarking
    • 8.6.2.4. Strategic initiatives
  • 8.6.3. Siemens Healthineers AG
    • 8.6.3.1. Company overview
    • 8.6.3.2. Financial performance
    • 8.6.3.3. Product benchmarking
    • 8.6.3.4. Strategic initiatives
  • 8.6.4. Medtronic
    • 8.6.4.1. Company overview
    • 8.6.4.2. Financial performance
    • 8.6.4.3. Product benchmarking
    • 8.6.4.4. Strategic initiatives
  • 8.6.5. Shimadzu Corporation
    • 8.6.5.1. Company overview
    • 8.6.5.2. Financial performance
    • 8.6.5.3. Product benchmarking
    • 8.6.5.4. Strategic initiatives
  • 8.6.6. Hologic, Inc.
    • 8.6.6.1. Company overview
    • 8.6.6.2. Financial performance
    • 8.6.6.3. Product benchmarking
    • 8.6.6.4. Strategic initiatives
  • 8.6.7. Canon Medical Systems Corporation
    • 8.6.7.1. Company overview
    • 8.6.7.2. Financial performance
    • 8.6.7.3. Product benchmarking
    • 8.6.7.4. Strategic initiatives
  • 8.6.8. Fujifilm Holdings Corporation
    • 8.6.8.1. Company overview
    • 8.6.8.2. Financial performance
    • 8.6.8.3. Product benchmarking
    • 8.6.8.4. Strategic initiatives
  • 8.6.9. Ziehm Imaging GmbH
    • 8.6.9.1. Company overview
    • 8.6.9.2. Financial performance
    • 8.6.9.3. Product benchmarking
    • 8.6.9.4. Strategic initiatives